Skip to main content

Reproductive Cancer Group

Understanding the cross-talk between ovarian cancer cells and the tumour micro-environment may allow us to understand how ovarian cancer spreads, its resistance to chemotherapy, and how to identify novel biomarkers for ovarian cancer detection.

Our current studies focus on the interactions of peritoneal cancer and ovarian cancer, and the mechanisms of how extracellular matrix proteins and proteases promote motility and tumour spread in ovarian cancer.

The Reproductive Cancer Group builds on an exciting and unique discovery by Dr Ricciardelli—that an extracellular matrix protein called versican correlates with cancer spread in prostate and breast cancer. This discovery suggests that cancer cells utilise proteins from the surrounding stromal cells to aid their movement and has led to versican protein expression being examined in many different cancer types.

Lead researcher: Dr Carmela Ricciardelli

Research team

Researchers 
Research support 
  • Tannith Noye
  • Zoe Price

Partnerships

  • Professor Ray Rodgers - Robinson Research Institute
  • Associate Professor Darryl Russell - Robinson Research Institute
  • Professor Peter Hoffman - University of South Australia
  • Dr Andrew Stephens - Hudson Institute of Medical Research, Victoria
  • Professor Rik Thompson - Institute of Health and Biomedical Innovation, Queensland

Interested in undertaking a postgraduate research degree with us?

We offer exciting opportunities for researchers at the honours, masters and PhD levels. Our research degrees are open to students from a broad range of backgrounds, and range from basic sciences to clinical research. If you are interested in human health, consider furthering your research career with us.

top